An overview of Notch3 function in vascular smooth muscle cells

Progress in Biophysics and Molecular Biology

Volumn 96, Issue 1-3, 2008, Pages 499-509

  Wang, Tao ^a   Baron, Martin ^b   Trump, Dorothy ^a  

^a School of Clinical and Laboratory Sciences   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

CADASIL; Notch signalling; Notch3; Vascular development; Vascular smooth muscle cells

Indexed keywords

NOTCH RECEPTOR; NOTCH3 PROTEIN, HUMAN;

ANIMAL; CYTOLOGY; HUMAN; PHYSIOLOGY; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, NOTCH;

MAMMALIA;

EID: 43049176532     PISSN: 00796107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbiomolbio.2007.07.006     Document Type: Review

References (59)

1. Alva J.A., and Iruela-Arispe M.L. Notch signaling in vascular morphogenesis. Curr. Opin. Hematol. 11 (2004) 278-283
2. Arboleda-Velasquez J.F., Rampal R., Fung E., Darland D.C., Liu M., Martinez M.C., Donahue C.P., Navarro-Gonzalez M.F., Libby P., D'Amore P.A., Aikawa M., Haltiwanger R.S., and Kosik K.S. Cadasil mutations impair Notch3 glycosylation by Fringe. Hum. Mol. Genet. 14 (2005) 1631-1639
3. Artavanis-Tsakonas S., Rand M.D., and Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 284 (1999) 770-776
4. Bardot B., Mok L.P., Thayer T., Ahimou F., and Wesley C. The Notch amino terminus regulates protein levels and Delta-induced clustering of Drosophila Notch receptors. Exp. Cell Res. 304 (2005) 202-223
5. Baron M. An overview of the Notch signalling pathway. Semin. Cell Dev. Biol. 14 (2003) 113-119
6. Baron M., Aslam H., Flasza M., Fostier M., Higgs J.E., Mazaleyrat S.L., and Wilkin M.B. Multiple levels of Notch signal regulation (review). Mol. Membr. Biol. 19 (2002) 27-38
7. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7 (2006) 678-689
8. Bruckner K., Perez L., Clausen H., and Cohen S. Glycosyltransferase activity of Fringe modulates Notch-Delta interactions. Nature 406 (2000) 411-415
9. Campos A.H., Wang W., Pollman M.J., and Gibbons G.H. Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation. Circ. Res. 91 (2002) 999-1006
10. Conlon R.A., Reaume A.G., and Rossant J. Notch1 is required for the coordinate segmentation of somites. Development 121 (1995) 1533-1545
11. Domenga V., Fardoux P., Lacombe P., Monet M., Maciazek J., Krebs L.T., Klonjkowski B., Berrou E., Mericskay M., Li Z., Tournier-Lasserve E., Gridley T., and Joutel A. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev. 18 (2004) 2730-2735
12. Dubroca C., Lacombe P., Domenga V., Maciazek J., Levy B., Tournier-Lasserve E., Joutel A., and Henrion D. Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke 36 (2005) 113-117
13. Fortini M.E., Rebay I., Caron L.A., and Artavanis-Tsakonas S. An activated Notch receptor blocks cell-fate commitment in the developing Drosophila eye. Nature 365 (1993) 555-557
14. Fryxell K.J., Soderlund M., and Jordan T.V. An animal model for the molecular genetics of CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). Stroke 32 (2001) 6-11
15. Haritunians T., Boulter J., Hicks C., Buhrman J., DiSibio G., Shawber C., Weinmaster G., Nofziger D., and Schanen C. CADASIL Notch3 mutant proteins localize to the cell surface and bind ligand. Circ. Res. 90 (2002) 506-508
16. Haritunians T., Chow T., De Lange R.P., Nichols J.T., Ghavimi D., Dorrani N., St Clair D.M., Weinmaster G., and Schanen C. Functional analysis of a recurrent missense mutation in Notch3 in CADASIL. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1242-1248
17. Harju M., Tuominen S., Summanen P., Viitanen M., Poyhonen M., Nikoskelainen E., Kalimo H., and Kivela T. Scanning laser Doppler flowmetry shows reduced retinal capillary blood flow in CADASIL. Stroke 35 (2004) 2449-2452
18. Haruki N., Kawaguchi K.S., Eichenberger S., Massion P.P., Olson S., Gonzalez A., Carbone D.P., and Dang T.P. Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res. 65 (2005) 3555-3561
19. Hutchinson H.G., Hein L., Fujinaga M., and Pratt R.E. Modulation of vascular development and injury by angiotensin II. Cardiovasc. Res. 41 (1999) 689-700
20. Iso T., Hamamori Y., and Kedes L. Notch signaling in vascular development. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 543-553
21. Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P., Alamowitch S., Domenga V., Cecillion M., Marechal E., Maciazek J., Vayssiere C., Cruaud C., Cabanis E.A., Ruchoux M.M., Weissenbach J., Bach J.F., Bousser M.G., and Tournier-Lasserve E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383 (1996) 707-710
22. Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P., Alamowitch S., Domenga V., Cecillion M., Marechal E., Maciazek J., Vayssiere C., Cruaud C., Cabanis E.A., Ruchoux M.M., Weissenbach J., Bach J.F., Bousser M.G., and Tournier-Lasserve E. Notch3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a Mendelian condition causing stroke and vascular dementia. Ann. N.Y. Acad. Sci. 826 (1997) 213-217
23. Joutel A., Vahedi K., Corpechot C., Troesch A., Chabriat H., Vayssiere C., Cruaud C., Maciazek J., Weissenbach J., Bousser M.G., Bach J.F., and Tournier-Lasserve E. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet 350 (1997) 1511-1515
24. Joutel A., Andreux F., Gaulis S., Domenga V., Cecillon M., Battail N., Piga N., Chapon F., Godfrain C., and Tournier-Lasserve E. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J. Clin. Invest. 105 (2000) 597-605
25. Joutel A., Favrole P., Labauge P., Chabriat H., Lescoat C., Andreux F., Domenga V., Cecillon M., Vahedi K., Ducros A., Cave-Riant F., Bousser M.G., and Tournier-Lasserve E. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet 358 (2001) 2049-2051
26. Joutel A., Monet M., Domenga V., Riant F., and Tournier-Lasserve E. Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling Pathway. Am. J. Hum. Genet. 74 (2004) 338-347
27. Karlstrom H., Beatus P., Dannaeus K., Chapman G., Lendahl U., and Lundkvist J. A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling. Proc. Natl. Acad. Sci. U.S.A 99 (2002) 17119-17124
28. Kawai-Kowase K., and Owens G.K. Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 292 (2007) C59-C69
29. Kitamoto T., Takahashi K., Takimoto H., Tomizuka K., Hayasaka M., Tabira T., and Hanaoka K. Functional redundancy of the Notch gene family during mouse embryogenesis: analysis of Notch gene expression in Notch3-deficient mice. Biochem. Biophys. Res. Commun. 331 (2005) 1154-1162
30. Krebs L.T., Xue Y., Norton C.R., Shutter J.R., Maguire M., Sundberg J.P., Gallahan D., Closson V., Kitajewski J., Callahan R., Smith G.H., Stark K.L., and Gridley T. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 14 (2000) 1343-1352
31. Krebs L.T., Xue Y., Norton C.R., Sundberg J.P., Beatus P., Lendahl U., Joutel A., and Gridley T. Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation. Genesis 37 (2003) 139-143
32. Lacombe P., Oligo C., Domenga V., Tournier-Lasserve E., and Joutel A. Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke 36 (2005) 1053-1058
33. Le Borgne R., Bardin A., and Schweisguth F. The roles of receptor and ligand endocytosis in regulating Notch signaling. Development 132 (2005) 1751-1762
34. Lesnik Oberstein S.A., Jukema J.W., Van Duinen S.G., Macfarlane P.W., van Houwelingen H.C., Breuning M.H., Ferrari M.D., and Haan J. Myocardial infarction in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Medicine (Baltimore) 82 (2003) 251-256
35. Low W.C., Santa Y., Takahashi K., Tabira T., and Kalaria R.N. CADASIL-causing mutations do not alter Notch3 receptor processing and activation. Neuroreport 17 (2006) 945-949
36. Lundkvist J., Zhu S., Hansson E.M., Schweinhardt P., Miao Q., Beatus P., Dannaeus K., Karlstrom H., Johansson C.B., Viitanen M., Rozell B., Spenger C., Mohammed A., Kalimo H., and Lendahl U. Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype. Genesis 41 (2005) 13-22
37. Marmur J.D., Poon M., Rossikhina M., and Taubman M.B. Induction of PDGF-responsive genes in vascular smooth muscle. Implications for the early response to vessel injury. Circulation 86 (1992) III53-III60
38. Miele L., Miao H., and Nickoloff B.J. NOTCH signaling as a novel cancer therapeutic target. Curr. Cancer Drug Targets 6 (2006) 313-323
39. Mitchell K.J., Pinson K.I., Kelly O.G., Brennan J., Zupicich J., Scherz P., Leighton P.A., Goodrich L.V., Lu X., Avery B.J., Tate P., Dill K., Pangilinan E., Wakenight P., Tessier-Lavigne M., and Skarnes W.C. Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat. Genet. 28 (2001) 241-249
40. Moloney D.J., Panin V.M., Johnston S.H., Chen J., Shao L., Wilson R., Wang Y., Stanley P., Irvine K.D., Haltiwanger R.S., and Vogt T.F. Fringe is a glycosyltransferase that modifies Notch. Nature 406 (2000) 369-375
41. Morrow D., Scheller A., Birney Y.A., Sweeney C., Guha S., Cummins P.M., Murphy R., Walls D., Redmond E.M., and Cahill P.A. Notch-mediated CBF-1/RBP-Jκ-dependent regulation of human vascular smooth muscle cell phenotype in vitro. Am. J. Physiol. Cell Physiol. 289 (2005) C1188-C1196
42. Morrow D., Sweeney C., Birney Y.A., Cummins P.M., Walls D., Redmond E.M., and Cahill P.A. Cyclic strain inhibits Notch receptor signaling in vascular smooth muscle cells in vitro. Circ. Res. 96 (2005) 567-575
43. Nicolas M., Wolfer A., Raj K., Kummer J.A., Mill P., van Noort M., Hui C.C., Clevers H., Dotto G.P., and Radtke F. Notch1 functions as a tumor suppressor in mouse skin. Nat. Genet. 33 (2003) 416-421
44. Peters N., Opherk C., Zacherle S., Capell A., Gempel P., and Dichgans M. CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk. Exp. Cell Res. 299 (2004) 454-464
45. Prakash N., Hansson E., Betsholtz C., Mitsiadis T., and Lendahl U. Mouse Notch 3 expression in the pre- and postnatal brain: relationship to the stroke and dementia syndrome CADASIL. Exp. Cell Res. 278 (2002) 31-44
46. Proweller A., Pear W.S., and Parmacek M.S. Notch signaling represses myocardin-induced smooth muscle cell differentiation. J. Biol. Chem. 280 (2005) 8994-9004
47. Ruchoux M.M., Domenga V., Brulin P., Maciazek J., Limol S., Tournier-Lasserve E., and Joutel A. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am. J. Pathol. 162 (2003) 329-342
48. Sharma P., Wang T., Brown M.J., and Schapira A.H. Fits and strokes. Lancet 358 (2001) 120
49. Stylianou S., Clarke R.B., and Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res. 66 (2006) 1517-1525
50. Sweeney C., Morrow D., Birney Y.A., Coyle S., Hennessy C., Scheller A., Cummins P.M., Walls D., Redmond E.M., and Cahill P.A. Notch 1 and 3 receptor signaling modulates vascular smooth muscle cell growth, apoptosis, and migration via a CBF-1/RBP-Jk dependent pathway. FASEB J. 18 (2004) 1421-1423
51. Swiatek P.J., Lindsell C.E., del Amo F.F., Weinmaster G., and Gridley T. Notch1 is essential for postimplantation development in mice. Genes Dev. 8 (1994) 707-719
52. Tiemann K., Weyer D., Djoufack P.C., Ghanem A., Lewalter T., Dreiner U., Meyer R., Grohe C., and Fink K.B. Increasing myocardial contraction and blood pressure in C57BL/6 mice during early postnatal development. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H464-H474
53. Villa N., Walker L., Lindsell C.E., Gasson J., Iruela-Arispe M.L., and Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech. Dev. 108 (2001) 161-164
54. Wang W., Campos A.H., Prince C.Z., Mou Y., and Pollman M.J. Coordinate Notch3-hairy-related transcription factor pathway regulation in response to arterial injury. Mediator role of platelet-derived growth factor and ERK. J. Biol. Chem. 277 (2002) 23165-23171
55. Wang W., Prince C.Z., Mou Y., and Pollman M.J. Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation. Resistance to Fas ligand-induced apoptosis. J. Biol. Chem. 277 (2002) 21723-21729
56. Wang W., Prince C.Z., Hu X., and Pollman M.J. HRT1 modulates vascular smooth muscle cell proliferation and apoptosis. Biochem. Biophys. Res. Commun. 308 (2003) 596-601
57. Weng A.P., Ferrando A.A., Lee W., Morris J.P.T., Silverman L.B., Sanchez-Irizarry C., Blacklow S.C., Look A.T., and Aster J.C. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306 (2004) 269-271
58. Wilkin M.B., and Baron M. Endocytic regulation of Notch activation and down-regulation (review). Mol. Membr. Biol. 22 (2005) 279-289
59. Wilkin M.B., Carbery A.M., Fostier M., Aslam H., Mazaleyrat S.L., Higgs J., Myat A., Evans D.A., Cornell M., and Baron M. Regulation of notch endosomal sorting and signaling by Drosophila Nedd4 family proteins. Curr. Biol. 14 (2004) 2237-2244